Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 158

1.

Comparison of the efficacy of new and conventional antipsychotic drugs in the treatment of behavioral and psychological symptoms of dementia (BPSD).

Gareri P, Cotroneo A, Lacava R, Seminara G, Marigliano N, Loiacono A, De Sarro G.

Arch Gerontol Geriatr Suppl. 2004;(9):207-15.

PMID:
15207416
2.

Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease.

Schneider LS, Tariot PN, Dagerman KS, Davis SM, Hsiao JK, Ismail MS, Lebowitz BD, Lyketsos CG, Ryan JM, Stroup TS, Sultzer DL, Weintraub D, Lieberman JA; CATIE-AD Study Group.

N Engl J Med. 2006 Oct 12;355(15):1525-38.

3.

Correlates of anticholinergic activity in patients with dementia and psychosis treated with risperidone or olanzapine.

Mulsant BH, Gharabawi GM, Bossie CA, Mao L, Martinez RA, Tune LE, Greenspan AJ, Bastean JN, Pollock BG.

J Clin Psychiatry. 2004 Dec;65(12):1708-14.

PMID:
15641877
4.

Clinical experience with risperidone in the treatment of behavioral and psychological symptoms of dementia.

Onor ML, Saina M, Trevisiol M, Cristante T, Aguglia E.

Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jan 30;31(1):205-9. Epub 2006 Oct 3.

PMID:
17020789
5.

Comparison of olanzapine and risperidone in the treatment of psychosis and associated behavioral disturbances in patients with dementia.

Deberdt WG, Dysken MW, Rappaport SA, Feldman PD, Young CA, Hay DP, Lehman DL, Dossenbach M, Degenhardt EK, Breier A.

Am J Geriatr Psychiatry. 2005 Aug;13(8):722-30.

PMID:
16085789
7.

Effect of risperidone on behavioral and psychological symptoms and cognitive function in dementia.

Rainer MK, Masching AJ, Ertl MG, Kraxberger E, Haushofer M.

J Clin Psychiatry. 2001 Nov;62(11):894-900.

PMID:
11775050
8.
9.

[Antipsychotics in bipolar disorders].

Vacheron-Trystram MN, Braitman A, Cheref S, Auffray L.

Encephale. 2004 Sep-Oct;30(5):417-24. Review. French.

PMID:
15627046
10.

A double-blind comparison of olanzapine versus risperidone in the acute treatment of dementia-related behavioral disturbances in extended care facilities.

Fontaine CS, Hynan LS, Koch K, Martin-Cook K, Svetlik D, Weiner MF.

J Clin Psychiatry. 2003 Jun;64(6):726-30.

PMID:
12823090
11.

Quetiapine versus risperidone in elderly patients with behavioural and psychological symptoms of dementia: efficacy, safety and cognitive function.

Rainer M, Haushofer M, Pfolz H, Struhal C, Wick W.

Eur Psychiatry. 2007 Sep;22(6):395-403. Epub 2007 May 4.

PMID:
17482432
12.

The management of psychogeriatric patient.

Zannino G, Gargiulo A, Lamenza F, Marotta MG, Barzotti T, Silvestri A, Ettorre E, Marigliano V.

Arch Gerontol Geriatr Suppl. 2004;(9):465-70.

PMID:
15207448
13.

Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease.

De Deyn PP, Carrasco MM, Deberdt W, Jeandel C, Hay DP, Feldman PD, Young CA, Lehman DL, Breier A.

Int J Geriatr Psychiatry. 2004 Feb;19(2):115-26.

PMID:
14758577
14.

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group.

Katz IR, Jeste DV, Mintzer JE, Clyde C, Napolitano J, Brecher M.

J Clin Psychiatry. 1999 Feb;60(2):107-15.

PMID:
10084637
15.

A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia.

Brodaty H, Ames D, Snowdon J, Woodward M, Kirwan J, Clarnette R, Lee E, Lyons B, Grossman F.

J Clin Psychiatry. 2003 Feb;64(2):134-43.

PMID:
12633121
16.

Cognitive effects of atypical antipsychotic medications in patients with Alzheimer's disease: outcomes from CATIE-AD.

Vigen CL, Mack WJ, Keefe RS, Sano M, Sultzer DL, Stroup TS, Dagerman KS, Hsiao JK, Lebowitz BD, Lyketsos CG, Tariot PN, Zheng L, Schneider LS.

Am J Psychiatry. 2011 Aug;168(8):831-9. doi: 10.1176/appi.ajp.2011.08121844. Epub 2011 May 15.

17.

A practical clinical trial comparing haloperidol, risperidone, and olanzapine for the acute treatment of first-episode nonaffective psychosis.

Crespo-Facorro B, Pérez-Iglesias R, Ramirez-Bonilla M, Martínez-García O, Llorca J, Luis Vázquez-Barquero J.

J Clin Psychiatry. 2006 Oct;67(10):1511-21.

PMID:
17107241
18.

The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.

Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.

Int J Geriatr Psychiatry. 2007 May;22(5):475-84.

PMID:
17471598
19.

A case for judicious use of risperidone and olanzapine in behavioral and psychological symptoms of dementia (BPSD). Favour.

Shah A, Suh GH.

Int Psychogeriatr. 2005 Mar;17(1):12-22; discussion 22-9. No abstract available.

PMID:
15945589
20.

Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: a randomized, double-blind trial.

Perlis RH, Baker RW, Zarate CA Jr, Brown EB, Schuh LM, Jamal HH, Tohen M.

J Clin Psychiatry. 2006 Nov;67(11):1747-53.

PMID:
17196055

Supplemental Content

Support Center